| Code | 02756 | ||||||||||
| MA number | 64/0928/10-S | ||||||||||
| Product Form: | int opo 3x5 ml/100 mg (liek.PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Bausch + Lomb Ireland Limited, Ireland | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | container PE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 13.12.2010 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Dozotens_03.2023.pdf
|
| SPC: |
SPC_Dozotens_03.2023.pdf
|
| Safety feature | Yes |
| Data update: | 22.11.2023 |
